← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2010Last known activity
Jan 6, 2022
Timeline
1960s
- Jan 1, 1968
Universidade de Passo Fundo— Founded
Drugs by trial phase (12 distinct, 8 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT05377619Reponsible party - principal investigatorPhase 1/Phase 2Jan 6, 2022
- NCT05377619Overall official - principal investigatorPhase 1/Phase 2Jan 6, 2022
- NCT05377619Lead sponsorPhase 1/Phase 2Jan 6, 2022
- NCT04398511Lead sponsorPhase 2Jan 7, 2019
- NCT04398511Reponsible party - principal investigatorPhase 2Jan 7, 2019
- NCT04398511Overall official - principal investigatorPhase 2Jan 7, 2019
- NCT03356730Study directorPhase 1Nov 19, 2017
- NCT03356730Lead sponsorPhase 1Nov 19, 2017
- NCT03356730Reponsible party - principal investigatorPhase 1Nov 19, 2017
- NCT02838849Lead sponsorPhase 1/Phase 2Aug 1, 2015
- NCT02838849Overall official - principal investigatorPhase 1/Phase 2Aug 1, 2015
- NCT02838849Reponsible party - principal investigatorPhase 1/Phase 2Aug 1, 2015
- NCT02704923Reponsible party - principal investigatorPhase 2Feb 1, 2015
- NCT02704923Lead sponsorPhase 2Feb 1, 2015
- NCT02794766Lead sponsorPhase 2Mar 1, 2014
Details
- Founded
- Passo Fundo, BR Jan 1, 1968
- Last known activity
- Jan 6, 2022